期刊文献+

survivin和p53在食管鳞癌中的表达及意义 被引量:3

Expression and significance of survivin and p53 in esophageal squamous carcinoma
下载PDF
导出
摘要 目的探讨凋亡抑制因子survivin和p53在食管鳞癌(ESC)组织中的表达及其与临床病理因素之间的关系。方法应用免疫组织化学S-P法和PowerVisionTM-9000(PV-9000)法检测60例ESC、15例食管良性肿瘤和10例癌旁正常食管黏膜组织中survivin和p53的表达。结果60例ESC中survivin和p53的阳性表达率分别为71.7%和65.0%,与食管良性肿瘤(13.3%,0)和癌旁食管正常黏膜组织(0,0)比较,差异均有显著性(P<0.001)。survivin和p53的表达强度与ESC的分化程度、临床分期和淋巴结转移均相关(P<0.05),而与肿瘤长度及部位均无相关(P>0.05)。survivin与p53的表达呈显著相关(P<0.01)。结论survivin和p53均与ESC的发生发展有关,二者在ESC的发展过程中可能起协同作用。联合检测survivin和p53在ESC中的表达水平,对判定其恶性程度及预后可能具有重要参考价值。 Objective To study the expression of survivin and p53 and their significance in esophageal squamous carcinoma(ESC). Methods The expression of survivin and p53 was examined immunohistochemically by SP and PowerVision^TM-9000(PV-9000) methods in 60 cases of ESC, 15 cases of esophageal benign tumor and 10 specimens of adjacent normal esophageal mucosa.Results The positive expression rate of survivin and p53 in ESC were 71.67% and 65.00%, respectively. There was significant difference between ESC and esophaseal benign tumor(13.33 %, 0), adjacent normal mucosa (0,0, P 〈 0.001). The expression intensity of survivin and p53 correlated with histopathological grade, clinical stage and lymph node metastasis ( P 〈 0.05). There was no correlation between the expression intensity of survivin, p53 and the location, the length of ESC ( P 〉 0.05). Kendall positive correlation was found between the expressive intensity of survivin and p53 ( P 〈 0.01). Conclusion The results suggest that survivin and p53 may play certain roles in the oncogenesis and progression of ESC, and may have synergetic action in the development of ESC. Ctimbined detection of the expression of survivin and p53 may be useful for evaluating malignancy and prognosis.
作者 马锴 项锋钢
出处 《中国肿瘤临床与康复》 2005年第5期398-400,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 食管肿瘤 SURVIVIN P53 免疫组织化学 Esophageal neoplasms survivin p53 Immunohistochemistry
  • 相关文献

参考文献13

  • 1Ambrosini G, Adida C, Altieri DC. A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma[J]. Nat Med,1997,3(8):917-921.
  • 2Kawasaki H, Altieri DC, Lu CD,et al.Inhibition of apoptosis by survivin predicts shorter survival rats in colorectal cancer[J].Cancer Res,1998,589(22):5071-5076.
  • 3Adida C,Crotty P,McGrath J,et al.Developmentally regulated expression of the novel cancer antiapoptosis gene survivin in human and mouse differentiation[J].Am J Pathol,1998,152(1):43-48.
  • 4王立新,林三仁,叶嗣,雷道年,周爱儒.胃癌组织及胃癌细胞系中p53的免疫组化研究[J].北京医科大学学报,1994,26(3):222-223. 被引量:3
  • 5Sarela AI,Macadam RCA, Farmery SM,et al.Inhibition of apoptosis gene,survivin,predicts death from recurrent colorectal carcinoma[J].Gut,2000,46(5):645-650.
  • 6Kato J,Kuwabara Y,Mitani M,et al.Expression of survivin in esophageal cancer:correlation with the prognosis and response to chemotherapy[J].Int J Cancer,2001,95(2):92-98.
  • 7Kobayashi K, Hatano MD, Dgasawara,et al.Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation[J].Proc Natl Acad Sci USA,1999,196:1457-1462.
  • 8Altieri DC,Marchisio PC,Marchisio C.survivin apoptosis: an interloper between cell death and cell proliferation in cancer[J].Lab Invest,1999,79:1327-1333.
  • 9LIULigang,PANTiecheng.The Correlation of p53 and nm23-H1 Expression with Invasivenes and Metastasis in Esophageal Carcinoma[J].The Chinese-German Journal of Clinical Oncology,2002,1(4):194-198. 被引量:2
  • 10Tanaka K, Iwamoto S, Gon G, et al. Expression of survivin and its relationship to loss apoptosis in breast cancinomas[J].Clin Cancer Res,2000,6:127-131.

二级参考文献13

  • 1[1]Sakurai K, Hata S, Amano S, Kimura T, et al. Immunohistochemical study of P53, P27 and PCNA expression in esophageal cancer. Gan To Kagaku Ryoho, 1998, 25 (9): 1269~1272.
  • 2[2]Hermanek P, Sobin LH. TNM classification of malignant tumours. 4th, ed. Berlin: springe-Verlag, 1987, 40.
  • 3[3]Polyak K, Lee MH, Erdjument-Bromage H, et al. Cloning of P27kipl, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 1994, 78(1): 59~66.
  • 4[4]Toyoshima H, Hunter T. P27, a novel inhibitor of Gl cyclin-cdk protein kinase activity, is ralated to P27. Cell, 1994, 78 (1): 67~74.
  • 5[5]Bennerr WP, Hollstein MC, HE, et al. Archival analysis of P53 genetic and protein alterations in chinese esophageal cancer.Oncogene, 1991, 6: 1779.
  • 6Steeg PS, Bevilacqua G, Kooper L,et al.Evidence for a novel gene associated with low tumor metastatic potential. J NatlCancer Inst, 1988, 80: 200.
  • 7Leone A, Flatow U, King CR, et al. Reduced tumor incidence, metastatic potentialand cytokine responsiveness of nm23-transfected melanoma cell. Cell, 1991, 65: 25.
  • 8Irayama R, Sawai S, Takagi Y, et al. Positive relationship between expression ofanti-metastatic factor (nm23 gene product or nucleotide diphosphate kinase) and goodprognosis in human breast cancer. J Natl Cancer Inst, 1991, 83: 1249.
  • 9Müller W, Schneiders A, Hommel G, et al. Expression of nm23 in gastriccarcinoma: association with tumor progression and poor prognosis. Cancer, 1998, 83: 2481.
  • 10Tannapfel A, Katalinic A, Kockerling F, et al. The prediction of lymph nodemetastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1and histopathological variables. Am J Gastroenterol, 1997, 92: 1182.

共引文献3

同被引文献43

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部